Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclo- propyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydro-imidazo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 2.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2011-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2011.06.023PMID 21737263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydroimid azo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 1.

  2011cited by this paper
• Smoothened antagonists for hair inhibition.

  2010cited by this paper
• Small‐Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics

  2010cited by this paper
• Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines.

  2010cited by this paper
• Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist.

  2010cited by this paper
• Discovery of a potent, orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor for clinical study: identification of (S)-2-((1S,2S,4R)-bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221).

  2010cited by this paper
• Smoothened antagonists: a promising new class of antitumor agents

  2009cited by this paper
• Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).

  2009cited by this paper
• 1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.

  2009cited by this paper
• Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.

  2009cited by this paper
• GDC-0449-a potent inhibitor of the hedgehog pathway.

  2009cited by this paper
• Basal cell carcinomas: attack of the hedgehog

  2008cited by this paper
• Hedgehog signaling pathway: Development of antagonists for cancer therapy

  2008cited by this paper
• Patching the gaps in Hedgehog signalling

  2007cited by this paper
• Targeting the Hedgehog pathway in cancer

  2006cited by this paper
• Two-hit model for progression of medulloblastoma preneoplasia in Patched heterozygous mice

  2006cited by this paper
• Linking DNA damage to medulloblastoma tumorigenesis in patched heterozygous knockout mice

  2006cited by this paper
• Endophilins interact with Moloney murine leukemia virus Gag and modulate virion production

  2003cited by this paper
• Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists

  2002cited by this paper
• Plasma pharmacokinetics and tissue distribution of a N-pyrrolo-[1,2-c]imidazolylphenyl sulfonamide in rats.

  2002cited by this paper
• Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened.

  2002cited by this paper
• Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade

  2002cited by this paper
• Hedgehog signaling in animal development: paradigms and principles.

  2001cited by this paper
• Biotransformation, excretion kinetics, and tissue distribution of an N-pyrrolo[1,2-c]imidazolylphenyl sulfonamide herbicide in rats.

  2001cited by this paper
• Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine

  2000cited by this paper
• Synthesis of Optically Active Imidazolines, Azapenams, Dioxocyclams, and Bis-dioxocyclams

  1997cited by this paper
• Kinetics and Mechanisms of Racemization: 5-Substituted Hydantoins (= Imidazolidine-2,4-diones) as Models of Chiral Drugs

  1996cited by this paper
• New preparations of the N-methyl-D-aspartate receptor antagonist, 4-(3-phosphonopropyl)-2-piperazinecarboxylic acid (CPP)

  1989cited by this paper
• Mutations affecting segment number and polarity in Drosophila

  1980cited by this paper

• Synthesis of Antiviral Drug Tecovirimat and Its Key Maleimide Intermediates Using Organocatalytic Mumm Rearrangement at Ambient Conditions

  2025cites this paper
• Unravelling the target landscape of tranylcypromines for new drug discovery

  2025cites this paper
• Recent Development in Hydantoins, Thiohydantoins, and Selenohydantoins as Anticancer Agents: Structure-activity Relationship and Design Strategies.

  2025cites this paper
• Medulloblastoma drugs in development: Current leads, trials and drawbacks.

  2021cites this paper
• New Pt(II) complexes with 3’-methyl tetrahydro-4H-thiopyranspiro-5’-hydantoin: synthesis, theoretical and cytotoxic investigation

  2020cites this paper
• Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma

  2019cites this paper
• Recent applications of hydantoin and thiohydantoin in medicinal chemistry.

  2019cites this paper
• Design of Hedgehog pathway inhibitors for cancer treatment

  2018cites this paper
• Strategies to target the Hedgehog signaling pathway for cancer therapy

  2018cites this paper
• Synthesis of Triazolo- and Oxadiazolopiperazines by Gold(I)-Catalyzed Domino Cyclization: Application to the Design of a Mitogen Activated Protein (MAP) Kinase Inhibitor.

  2018cites this paper
• Enantioselective Synthesis of 5,5-Disubstituted Hydantoins by Brønsted Base/H-Bond Catalyst Assisted Michael Reactions of a Design Template.

  2018cites this paper
• A novel synthetic approach to hydroimidazo[1,5-b]pyridazines by the recyclization of itaconimides and HPLC–HRMS monitoring of the reaction pathway

  2017cites this paper
• Discovery of Hedgehog Antagonists for Cancer Therapy.

  2017cites this paper
• Design, Synthesis, and Structure-Activity Relationship of Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity.

  2017cites this paper
• Design, synthesis and evaluation of novel tetrahydrothieno[3,2-c]pyridine derivatives as potent smoothened antagonists

  2016cites this paper
• N-Aryl-5-aminopyrazole: a versatile architecture in medicinal chemistry.

  2015cites this paper
• Hedgehog inhibitors: a patent review (2013 – present)

  2015cites this paper
• Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics.

  2015cites this paper
• Design, synthesis, and structure--activity-relationship of tetrahydrothiazolopyridine derivatives as potent smoothened antagonists.

  2015cites this paper
• Smoothened inhibitors in the treatment of advanced basal cell carcinomas

  2014cites this paper
• Tranylcypromine Substituted cis-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D3 Receptor Antagonists

  2014cites this paper
• Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies

  2014cites this paper
• Synthesis and evaluation of 4-(2-pyrimidinylamino) benzamides inhibitors of hedgehog signaling pathway.

  2014cites this paper
• Five-membered heteroaromatic ring fused-pyrimidine derivatives: design, synthesis, and hedgehog signaling pathway inhibition study.

  2014cites this paper
• Design, synthesis, and evaluation of pyrrolo[2,1-f][1,2,4]triazine derivatives as novel hedgehog signaling pathway inhibitors.

  2014cites this paper
• Design, Synthesis and Biological Evaluation of Small Molecule Inhibitors of the Hedgehog Signaling Pathway

  2014influential citation
• Structure–Activity Relationships and Mechanism of Action of Small Molecule Smoothened Modulators Discovered by High-Throughput Screening and Rational Design

  2014cites this paper
• Synthesis, LSD1 Inhibitory Activity, and LSD1 Binding Model of Optically Pure Lysine-PCPA Conjugates

  2014cites this paper
• Scaffold hopping approach to a new series of smoothened antagonists.

  2014cites this paper
• Hedgehog pathway inhibitors: a patent review (2009 – present)

  2013cites this paper
• Toward a systems‐level understanding of the Hedgehog signaling pathway: defining the complex, robust, and fragile

  2013cites this paper
• An Overview of Phenylcyclopropylamine Derivatives: Biochemical and Biological Significance and Recent Developments

  2013cites this paper
• The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitors.

  2013cites this paper
• Identification of a novel Smoothened antagonist that potently suppresses Hedgehog signaling.

  2012cites this paper
• Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer

  2012cites this paper
• Centrosomes and cilia in health and disease Mechanisms of Biogenesis and Function

  2012cites this paper
• DECOUVERTE ET CARACTERISATION PHARMACOLOGIQUE DE NOUVEAUX ANTAGONISTES DU RECEPTEUR SMOOTHENED : LES COMPOSES MRT

  2011cites this paper
• Identification of a series of 4-[3-(quinolin-2-yl)-1,2,4-oxadiazol-5-yl]piperazinyl ureas as potent smoothened antagonist hedgehog pathway inhibitors.

  2011cites this paper
• N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists.

  2011cites this paper
• Identification of MK-5710 ((8aS)-8a-methyl-1,3-dioxo-2-[(1S,2R)-2-phenylcyclopropyl]-N-(1-phenyl-1H-pyrazol-5-yl)hexahydroimid azo[1,5-a]pyrazine-7(1H)-carboxamide), a potent smoothened antagonist for use in Hedgehog pathway dependent malignancies, part 1.

  2011cites this paper